Doctor profile · Federal record
Dr. Matthew Levine, M.D
Endocrinology, Diabetes & Metabolism Physician (CMS: Endocrinology) · Specialist · La Jolla, CA
- NPI 1801994231
- Accepts Medicare
- 26 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
9898 Genesee Ave
La Jolla, CA 920371205
(858) 824-5000 - Mailing address
-
10790 Rancho Bernardo RD
San Diego, CA 921275705
Credentials & registration
- NPI registered
- September 2006 — 20 yrs on file
- Profile last updated
- October 26, 2017
- Year of graduation
- 2000 — 26 yrs since
- Specialty taxonomy
- 207RE0101X — NUCC code
- State license (1)
- California #A77126
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1801994231. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
2,301
Distinct HCPCS
7
Medicare allowed
$135,828
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J0897 |
Injection, denosumab, 1 mg | 1,380 | 20 | $22 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 501 | 303 | $136 | |
99204 |
New patient office or other outpatient visit, 45-59 minutes | 100 | 100 | $176 | |
96372 |
Injection of drug or substance under skin or into muscle | 99 | 39 | $15 | |
95251 |
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 94 | 61 | $36 | |
76536 |
Ultrasound scan of head and neck soft tissue | 72 | 72 | $126 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 55 | 53 | $96 |
In context: peer comparison
Among 8 peers in this city , average services per provider: 907. This provider delivers 2.5× the peer median.Open Payments
Industry payments received
All-time total
$8,770
Transactions
56
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Novo Nordisk Inc | 12 | $7,556.78 | |
| AstraZeneca Pharmaceuticals LP | 5 | $184.48 | |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 11 | $156.35 | |
| Kyowa Kirin, Inc. | 3 | $86.05 | |
| Xeris Pharmaceuticals, Inc. | 4 | $81.99 | |
| SANOFI-AVENTIS U.S. LLC | 2 | $77.06 | |
| Verity Pharmaceuticals Inc. | 2 | $65.95 | |
| Alexion Pharmaceuticals, Inc. | 2 | $60.24 | |
| Novartis Pharmaceuticals Corporation | 2 | $56.51 | |
| Radius Health, Inc. | 2 | $50.30 | |
| Mannkind Corporation | 2 | $46.46 | |
| Lilly USA, LLC | 2 | $42.94 | |
| Amgen Inc. | 2 | $42.17 | |
| BETA BIONICS, INC. | 3 | $41.46 | |
| Antares Pharma, Inc. | 2 | $40.60 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
2,393
Patients
676
Total drug cost
$1,504,009
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Ozempic (Semaglutide) | Brand | 259 | 53 | $408,446 |
| Metformin Hcl | Generic | 255 | 76 | $4,097 |
| Levothyroxine Sodium | Generic | 252 | 73 | $4,665 |
| Synthroid (Levothyroxine Sodium) | Brand | 249 | 63 | $27,073 |
| Metformin Hcl Er (Metformin Hcl) | Brand | 242 | 71 | $5,515 |
| Trulicity (Dulaglutide) | Brand | 174 | 41 | $297,353 |
| Jardiance (Empagliflozin) | Brand | 169 | 50 | $245,968 |
| Farxiga (Dapagliflozin Propanediol) | Brand | 140 | 38 | $180,124 |
| Lantus Solostar (Insulin Glargine,hum.Rec.Anlog) | Brand | 132 | 47 | $92,968 |
| Atorvastatin Calcium | Generic | 106 | 29 | $1,371 |
Hospital affiliations
Frequently asked questions
What is Dr. Matthew Levine's medical specialty?
Dr. Matthew Levine practices Endocrinology, Diabetes & Metabolism Physician in La Jolla, CA.
Where does Dr. Matthew Levine practice?
Dr. Matthew Levine practices at 9898 Genesee Ave, La Jolla, CA 920371205. Office phone: 8588245000.
What is Dr. Matthew Levine's NPI?
Dr. Matthew Levine's National Provider Identifier (NPI) is 1801994231, issued by NPPES.
Does Dr. Matthew Levine accept Medicare assignment?
Yes. Dr. Matthew Levine accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Matthew Levine commonly perform?
Top Medicare-reported procedures in 2023: Injection, denosumab, 1 mg (HCPCS J0897); Established patient office or other outpatient visit (HCPCS 99214); New patient office or other outpatient visit (HCPCS 99204). Source: CMS Medicare Physician & Other Practitioners file.